BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 21310211)

  • 21. Platelet-derived growth factor (PDGF) stimulates the association of SH2-Bbeta with PDGF receptor and phosphorylation of SH2-Bbeta.
    Rui L; Carter-Su C
    J Biol Chem; 1998 Aug; 273(33):21239-45. PubMed ID: 9694882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of small molecule platelet-derived growth factor receptor (PDGFR) inhibitors in the treatment of neoplastic disorders.
    Roskoski R
    Pharmacol Res; 2018 Mar; 129():65-83. PubMed ID: 29408302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the adaptor protein Lnk in leukemia cells.
    Gery S; Gueller S; Nowak V; Sohn J; Hofmann WK; Koeffler HP
    Exp Hematol; 2009 May; 37(5):585-592.e2. PubMed ID: 19375649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived growth factor receptor-beta (PDGFR-beta) activation promotes its association with the low density lipoprotein receptor-related protein (LRP). Evidence for co-receptor function.
    Newton CS; Loukinova E; Mikhailenko I; Ranganathan S; Gao Y; Haudenschild C; Strickland DK
    J Biol Chem; 2005 Jul; 280(30):27872-8. PubMed ID: 15944146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosines 1021 and 1009 are phosphorylation sites in the carboxy terminus of the platelet-derived growth factor receptor beta subunit and are required for binding of phospholipase C gamma and a 64-kilodalton protein, respectively.
    Valius M; Bazenet C; Kazlauskas A
    Mol Cell Biol; 1993 Jan; 13(1):133-43. PubMed ID: 7678051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyr-716 in the platelet-derived growth factor beta-receptor kinase insert is involved in GRB2 binding and Ras activation.
    Arvidsson AK; Rupp E; Nånberg E; Downward J; Rönnstrand L; Wennström S; Schlessinger J; Heldin CH; Claesson-Welsh L
    Mol Cell Biol; 1994 Oct; 14(10):6715-26. PubMed ID: 7935391
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural coincidence of alpha PDGFR epitopes binding to platelet-derived growth factor-AA and a potent neutralizing monoclonal antibody.
    Yu JC; Mahadevan D; LaRochelle WJ; Pierce JH; Heidaran MA
    J Biol Chem; 1994 Apr; 269(14):10668-74. PubMed ID: 7511602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Grb7 is a downstream signaling component of platelet-derived growth factor alpha- and beta-receptors.
    Yokote K; Margolis B; Heldin CH; Claesson-Welsh L
    J Biol Chem; 1996 Nov; 271(48):30942-9. PubMed ID: 8940081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulation of the platelet-derived growth factor beta receptor signaling pathway activates protein kinase C-delta.
    Li W; Yu JC; Michieli P; Beeler JF; Ellmore N; Heidaran MA; Pierce JH
    Mol Cell Biol; 1994 Oct; 14(10):6727-35. PubMed ID: 7935392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis.
    Yokouchi M; Wakioka T; Sakamoto H; Yasukawa H; Ohtsuka S; Sasaki A; Ohtsubo M; Valius M; Inoue A; Komiya S; Yoshimura A
    Oncogene; 1999 Jan; 18(3):759-67. PubMed ID: 9989826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction.
    Seifert RA; van Koppen A; Bowen-Pope DF
    J Biol Chem; 1993 Feb; 268(6):4473-80. PubMed ID: 8440729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation.
    Li Y; He X; Schembri-King J; Jakes S; Hayashi J
    J Immunol; 2000 May; 164(10):5199-206. PubMed ID: 10799879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity.
    Klinghoffer RA; Duckworth B; Valius M; Cantley L; Kazlauskas A
    Mol Cell Biol; 1996 Oct; 16(10):5905-14. PubMed ID: 8816504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine phosphatase SHP-2 is involved in regulation of platelet-derived growth factor-induced migration.
    Qi JH; Ito N; Claesson-Welsh L
    J Biol Chem; 1999 May; 274(20):14455-63. PubMed ID: 10318871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J; Uecker A; Kroll J; Frank H; Mayr U; Bjorge JD; Fujita D; Gazit A; Hombach V; Levitzki A; Böhmer FD
    Circ Res; 1999 Jul; 85(1):12-22. PubMed ID: 10400906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effects of carboxy-terminal sequence deletions on platelet-derived growth factor receptor signaling activities and interactions with cellular substrates.
    Seedorf K; Millauer B; Kostka G; Schlessinger J; Ullrich A
    Mol Cell Biol; 1992 Oct; 12(10):4347-56. PubMed ID: 1406626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphorylation of tyrosine 720 in the platelet-derived growth factor alpha receptor is required for binding of Grb2 and SHP-2 but not for activation of Ras or cell proliferation.
    Bazenet CE; Gelderloos JA; Kazlauskas A
    Mol Cell Biol; 1996 Dec; 16(12):6926-36. PubMed ID: 8943348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lnk adaptor suppresses radiation resistance and radiation-induced B-cell malignancies by inhibiting IL-11 signaling.
    Louria-Hayon I; Frelin C; Ruston J; Gish G; Jin J; Kofler MM; Lambert JP; Adissu HA; Milyavsky M; Herrington R; Minden MD; Dick JE; Gingras AC; Iscove NN; Pawson T
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20599-604. PubMed ID: 24297922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessing the activity of cediranib, a VEGFR-2/3 tyrosine kinase inhibitor, against VEGFR-1 and members of the structurally related PDGFR family.
    Brave SR; Ratcliffe K; Wilson Z; James NH; Ashton S; Wainwright A; Kendrew J; Dudley P; Broadbent N; Sproat G; Taylor S; Barnes C; Silva JC; Farnsworth CL; Hennequin L; Ogilvie DJ; Jürgensmeier JM; Shibuya M; Wedge SR; Barry ST
    Mol Cancer Ther; 2011 May; 10(5):861-73. PubMed ID: 21441409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of platelet-derived growth factor receptor activation by afadin through SHP-2: implications for cellular morphology.
    Nakata S; Fujita N; Kitagawa Y; Okamoto R; Ogita H; Takai Y
    J Biol Chem; 2007 Dec; 282(52):37815-25. PubMed ID: 17971444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.